Anthracyclines News and Research

RSS
Potential breast cancer patients for new immune-targeting therapies

Potential breast cancer patients for new immune-targeting therapies

EAE, ASE to issue echocardiography guidelines for early detection of cardio toxicity

EAE, ASE to issue echocardiography guidelines for early detection of cardio toxicity

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Trastuzumab drug increases risk of heart problems in elderly breast cancer patients

Trastuzumab drug increases risk of heart problems in elderly breast cancer patients

ImmunoGen's IMGN901 Phase I trial data on multiple myeloma presented at ASCO 2011

ImmunoGen's IMGN901 Phase I trial data on multiple myeloma presented at ASCO 2011

Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast cancer at CTRC-AACR SABCS

Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast cancer at CTRC-AACR SABCS

Multi-disciplinary approach increases breast cancer survival rate: Study

Multi-disciplinary approach increases breast cancer survival rate: Study

Impact of cancer treatment on cardiovascular function

Impact of cancer treatment on cardiovascular function

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Survival improving in patients with HER2 positive metastatic breast cancer

Survival improving in patients with HER2 positive metastatic breast cancer

Survival rate is improving in HER2 positive breast cancer patients

Survival rate is improving in HER2 positive breast cancer patients

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

SpePharm Holding acquires global rights to Savene from TopoTarget

SpePharm Holding acquires global rights to Savene from TopoTarget

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

CytRx announces its plans to advance multiple oncology development programs in 2010

CytRx announces its plans to advance multiple oncology development programs in 2010

Trabectedin now available for patients with advanced soft tissue sarcoma

Trabectedin now available for patients with advanced soft tissue sarcoma

INS cites FDA-approved Totect antidote for anthracycline extravasations

INS cites FDA-approved Totect antidote for anthracycline extravasations

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.